Luteinizing hormone

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates
Name
Luteinizing hormone
Accession Number
DB14741
Type
Biotech
Groups
Approved
Biologic Classification
Protein Based Therapies
Hormones
Description
Not Available
Protein chemical formula
Not Available
Protein average weight
Not Available
Sequences
Not Available
Synonyms
  • Gonadotropin, luteinizing hormone
  • LH
  • Luteinising hormone
  • Luteinising hormone (human)
  • Luteinizing gonadotropic hormone
  • Luteinizing hormone
  • Luteotropic hormone
  • Pituitary luteinizing hormone
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Humegon Inj 75 I.U.Luteinizing hormone (75 unit) + Follitropin (75 unit) + Sodium chloride (.9 %)Liquid; Powder, for solutionIntramuscularOrganon Canada Ltd Ltee1993-12-312006-08-17Canada
MenopurLuteinizing hormone (75 [iU]/1mL) + Follitropin (75 [iU]/1mL) + Sodium chloride (9 mg/1mL)KitSubcutaneousFerring Pharmaceuticals Inc.2004-10-29Not applicableUs
Pergonal 75 I.U.Luteinizing hormone (75 unit) + Follitropin (75 unit)Powder, for solutionIntramuscularEmd Serono, A Division Of Emd Inc., Canada1979-12-312007-05-07Canada
RepronexLuteinizing hormone (75 [iU]/2mL) + Follitropin (75 [iU]/2mL)KitIntramuscular; SubcutaneousFerring Pharmaceuticals1999-08-272014-12-31Us
Categories
UNII
8XA4VN1LH4
CAS number
9002-67-9

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Wikipedia
Luteinizing_hormone

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
0RecruitingBasic ScienceSleep Restriction1
1RecruitingBasic ScienceSleep Restriction1
2Active Not RecruitingTreatmentAdenocarcinoma, Prostate / Diseases of Male Genital Organs / Prostate Cancer / PSA Level Greater Than Ten / Stage IIB Prostate Cancer AJCC v8 / Stage IIC Prostate Cancer AJCC v8 / Stage IIIA Prostate Cancer AJCC v8 / Stage IIIC Prostate Cancer AJCC v8 / Testosterone Greater Than 150 ng/dL1
2CompletedTreatmentInfertility / Ovulation induction therapy1
2CompletedTreatmentProstate Cancer1
2Not Yet RecruitingTreatmentAcquired Hypogonadotropic Hypogonadism1
2RecruitingTreatmentAdenocarcinoma, Prostate / Stage IIC Prostate Cancer AJCC v8 / Stage III Prostate Cancer AJCC v8 / Stage IIIA Prostate Cancer AJCC v8 / Stage IIIB Prostate Cancer AJCC v8 / Stage IIIC Prostate Cancer AJCC v8 / Stage IVA Prostate Cancer AJCC v81
2RecruitingTreatmentStage II Prostate Adenocarcinoma / Stage III Prostate Adenocarcinoma1
2TerminatedTreatmentInfertility / Ovulation induction therapy1
2TerminatedTreatmentProstate Cancer1
2, 3TerminatedTreatmentProstate Cancer1
3Active Not RecruitingTreatmentProstate Cancer1
3CompletedTreatmentHypogonadism1
3CompletedTreatmentInfertility / Ovarian Stimulation1
3CompletedTreatmentOvarian Stimulation1
3CompletedTreatmentProstate Cancer2
3Not Yet RecruitingTreatmentProstate Cancer2
3RecruitingTreatmentProstate Cancer1
3TerminatedTreatmentReproductive Techniques, Assisted1
3Unknown StatusTreatmentProstate Cancer1
4CompletedBasic ScienceControlled Ovarian Stimulation / Infertility1
4CompletedOtherCardiovascular Heart Disease / Prostatic Neoplasms1
4CompletedTreatmentAssisted Reproductive Technology therapy / Infertility1
4CompletedTreatmentPregnancy1
4Not Yet RecruitingTreatmentFemale Infertility1
4TerminatedTreatmentIdiopathic Hypogonadotropic Hypogonadism1
4Unknown StatusTreatmentInfertility1
Not AvailableActive Not RecruitingTreatmentStage III Prostate Cancer1
Not AvailableCompletedNot AvailableBMI >30 kg/m21
Not AvailableCompletedDiagnosticHypogonadism / Spinal Cord Injuries (SCI)1
Not AvailableCompletedPreventionPorphyria1
Not AvailableCompletedScreeningOther Diseases or Conditions1
Not AvailableCompletedTreatmentFemale Infertility / Female Subfertility1
Not AvailableNot Yet RecruitingTreatmentStage IV Prostate Cancer1
Not AvailableRecruitingTreatmentOligometastasis / Prostate Cancer1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Liquid; powder, for solutionIntramuscular
KitSubcutaneous
Powder, for solutionIntramuscular
KitIntramuscular; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available

Drug created on February 27, 2019 16:25 / Updated on February 02, 2020 03:16